MX353427B - Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas. - Google Patents

Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.

Info

Publication number
MX353427B
MX353427B MX2013014144A MX2013014144A MX353427B MX 353427 B MX353427 B MX 353427B MX 2013014144 A MX2013014144 A MX 2013014144A MX 2013014144 A MX2013014144 A MX 2013014144A MX 353427 B MX353427 B MX 353427B
Authority
MX
Mexico
Prior art keywords
pharmaceutical
core
coating composition
composition suitable
dosage forms
Prior art date
Application number
MX2013014144A
Other languages
English (en)
Other versions
MX2013014144A (es
Inventor
Meier Christian
Assmus Manfred
Nollenberger Kathrin
Hendrik Schattka Jan
Leubert René
Hermes Florian
Dassinger Thomas
Riermeier Thomas
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2013014144A publication Critical patent/MX2013014144A/es
Publication of MX353427B publication Critical patent/MX353427B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/12—Polymerisation in non-solvents
    • C08F2/16—Aqueous medium
    • C08F2/22—Emulsion polymerisation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06—Polymerisation of acrylate or methacrylate esters on to polymers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La invención se relaciona a una composición de recubrimiento adecuada para el recubrimiento de una forma de dosis farmacéutica o nutracéutica, que comprende un núcleo que comprende uno o más ingredientes activos farmacéuticos o nutracéuticos, en donde la composición de recubrimiento comprende por lo menos 20% en peso de una composición de polímero de núcleo/cubierta entérica derivada de un proceso de polimerización de emulsión, en donde ya sea el núcleo de la composición de polímero núcleo/cubierta es formada por un polímero o copolímero no reticulado, insoluble en agua y la cubierta de la composición de polímero de núcleo/cubierta es formada por un polímero o copolímero aniónico o viceversa.
MX2013014144A 2011-06-17 2011-06-17 Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas. MX353427B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/060094 WO2012171575A1 (en) 2011-06-17 2011-06-17 Coating composition suitable for pharmaceutical or nutraceutical dosage forms

Publications (2)

Publication Number Publication Date
MX2013014144A MX2013014144A (es) 2014-01-23
MX353427B true MX353427B (es) 2018-01-12

Family

ID=44627582

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014144A MX353427B (es) 2011-06-17 2011-06-17 Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.

Country Status (17)

Country Link
US (1) US9844511B2 (es)
EP (1) EP2720682B1 (es)
JP (1) JP5847303B2 (es)
KR (1) KR101799624B1 (es)
CN (1) CN103608001B (es)
AU (1) AU2011370762A1 (es)
BR (1) BR112013032095A8 (es)
CA (1) CA2839689C (es)
ES (1) ES2616006T3 (es)
HK (1) HK1191572A1 (es)
HU (1) HUE033111T2 (es)
IL (1) IL229166B (es)
MX (1) MX353427B (es)
PL (1) PL2720682T3 (es)
RU (1) RU2606588C2 (es)
SI (1) SI2720682T1 (es)
WO (1) WO2012171575A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2649806C2 (ru) 2011-06-17 2018-04-04 Эвоник Рем ГмбХ Желудочно-резистентная фармацевтическая или нутрицевтическая композиция с устойчивостью к воздействию этанола
ES2786312T3 (es) * 2014-11-26 2020-10-09 Evonik Operations Gmbh Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol
US11980692B2 (en) 2017-11-17 2024-05-14 Evonik Operations Gmbh Process for preparing a coated hard shell capsule
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
KR20210099064A (ko) 2018-12-05 2021-08-11 에보니크 오퍼레이션즈 게엠베하 중합체성 입자의 제조 방법
KR20210139263A (ko) 2019-03-14 2021-11-22 에보닉 오퍼레이션스 게엠베하 코어-쉘 중합체 및 셀룰로오스를 포함하는 캡슐 쉘
CA3134989A1 (en) * 2019-04-30 2020-11-05 Ashish Guha Pellet and multi-unit pellet system (mups)
CN113950321A (zh) * 2019-06-13 2022-01-18 赢创运营有限公司 包含共聚物混合物和水溶性纤维素的粉末组合物
KR20240012433A (ko) 2021-05-25 2024-01-29 에보니크 오퍼레이션즈 게엠베하 변형 방출 코팅을 갖는 경질 쉘 캡슐
BR112023024450A2 (pt) 2021-05-25 2024-03-12 Evonik Operations Gmbh Cápsula de casca dura revestida com polímero, uso e processo de preparação da mesma
EP4176874A1 (en) 2021-11-09 2023-05-10 Evonik Operations GmbH Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system
WO2023174722A1 (en) 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5
WO2023214016A1 (en) 2022-05-06 2023-11-09 Evonik Operations Gmbh Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2135073C3 (de) 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4325856A (en) 1980-01-02 1982-04-20 The Dow Chemical Company Sequential emulsion polymerization process
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
US4677003A (en) * 1985-04-30 1987-06-30 Rohm And Haas Company Microsuspension process for preparing solvent core sequential polymer dispersion
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
WO1997003112A1 (en) * 1995-07-07 1997-01-30 Mitsubishi Rayon Co., Ltd. Powdery material and modifier for cementitious material
DE10011447A1 (de) 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
NZ528957A (en) * 2001-04-18 2005-05-27 Nostrum Pharmaceuticals Inc A novel coating for a sustained release pharmaceutical composition
ES2233876T3 (es) * 2001-12-19 2005-06-16 Astrazeneca Ab Nuevo recubrimiento de pelicula que contiene un copolimero acrilato de etilo/metacrilato de metilo y poli (acetato de vinilo).
JP3640921B2 (ja) 2001-12-28 2005-04-20 クラリアントポリマー株式会社 合成樹脂エマルジョン、それを含んでなる易水膨潤性粘着剤組成物、および合成樹脂エマルジョンの製造方法
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
MXPA04010956A (es) 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
GB2407501A (en) * 2003-11-03 2005-05-04 Ist Superiore Sanita Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell
WO2005056619A1 (en) * 2003-12-15 2005-06-23 Council Of Scientific & Industrial Research pH SENSITIVE POLYMER AND PROCESS FOR PREPARATION THEREOF
DE102004011349A1 (de) 2004-03-05 2005-09-22 Basf Ag Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten
US20060235131A1 (en) * 2005-04-15 2006-10-19 Hughes Kathleen A Process for preparing aqueous dispersions of multistage emulsion polymers
DE102006051020A1 (de) 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
PL2187875T3 (pl) 2007-09-21 2013-01-31 Evonik Roehm Gmbh Kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu dla nieopioidów z odpornością przed wpływem etanolu
CA2699227C (en) 2007-09-21 2014-12-02 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
PL2341899T3 (pl) 2008-09-24 2015-05-29 Evonik Roehm Gmbh Opioidowa kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu z odpornością na działanie etanolu
CA2738197C (en) 2008-09-24 2016-01-05 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
WO2010105672A1 (en) 2009-03-18 2010-09-23 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
CN102365083A (zh) * 2009-03-18 2012-02-29 赢创罗姆有限公司 采用包含聚合物混合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
CN102470112A (zh) * 2009-07-30 2012-05-23 赢创罗姆有限公司 包含阴离子聚合物材料和含6-22个碳原子的饱和单羧酸的盐的组合物

Also Published As

Publication number Publication date
EP2720682B1 (en) 2016-11-23
CA2839689C (en) 2018-05-01
IL229166B (en) 2018-01-31
SI2720682T1 (sl) 2017-05-31
US20140086997A1 (en) 2014-03-27
WO2012171575A1 (en) 2012-12-20
RU2014101227A (ru) 2015-09-27
CN103608001B (zh) 2015-10-14
JP5847303B2 (ja) 2016-01-20
BR112013032095A2 (pt) 2016-12-13
BR112013032095A8 (pt) 2022-07-05
EP2720682A1 (en) 2014-04-23
IL229166A0 (en) 2013-12-31
KR20140041543A (ko) 2014-04-04
CN103608001A (zh) 2014-02-26
MX2013014144A (es) 2014-01-23
CA2839689A1 (en) 2012-12-20
ES2616006T3 (es) 2017-06-09
RU2606588C2 (ru) 2017-01-10
KR101799624B1 (ko) 2017-11-20
JP2014518205A (ja) 2014-07-28
US9844511B2 (en) 2017-12-19
HK1191572A1 (en) 2014-08-01
PL2720682T3 (pl) 2017-05-31
AU2011370762A1 (en) 2013-11-14
HUE033111T2 (en) 2017-11-28

Similar Documents

Publication Publication Date Title
MX353427B (es) Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.
MX353426B (es) Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas.
MX355662B (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influencia de etanol.
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
GEP20166457B (en) Low-oil pharmaceutical emulsion compositions comprising progestogen
WO2016137235A3 (ko) 마이크로 rna를 유효 성분으로 포함하는 암 치료용 약학 조성물
PH12015500106B1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
PH12017502326B1 (en) Orodispersible dosage unit containing an estetrol component
MX348899B (es) Composiciones de productos de consumo que comprenden emulsiones de organopolisiloxano.
BR112012026596A2 (pt) método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas
MX2017015465A (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.
MX2015008295A (es) Composicion cosmetica.
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
WO2016190682A3 (ko) 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
SG11201810274RA (en) Hair treatment agent
MX363699B (es) Producto de comicronizacion que comprende acetato de ulipristal.
BR112015009453A2 (pt) composição farmacêutica estável de peg-interferona alfa-2b
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
ZA201905664B (en) Novel dosage form
EA201390844A1 (ru) Комплексный состав, содержащий гидрохлорид лерканидипина и валсартан, и способ его получения
WO2016195194A3 (ko) 신규한 tlr2 길항제
WO2013091970A3 (de) Mittel zur temporären verformung keratinischer fasern auf grundlage einer kombination spezifischer filmbildender polymere
WO2014122671A3 (en) Solid oral compositions of saxagliptin
CA3010572A1 (en) Microcapsules and process for preparation of microcapsules

Legal Events

Date Code Title Description
FG Grant or registration